3191 results for «684»
3191 results
TAVI coronary access
22 May 2025 – From EuroPCR 2025
Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...
Overcoming complex anatomy in NSTEMI
23 May 2025 – From EuroPCR 2025
Explore advanced interventional strategies addressing complex anatomy in NSTEMI patients. This session presents challenging cases including unusual STEMI presentations with cardiogenic shock in Takayasu arteritis, subtotal aorto-ostial lesions in young patients, and management of giant coronary artery aneurysms, emphasizing tailored approaches to optimize outcomes.
Treatment of special anatomical scenarios in STEMI patients
23 May 2025 – From EuroPCR 2025
This session examines special anatomical scenarios in STEMI patients, focusing on the impact of bifurcation angles, calcium burden, and active side branch protection techniques. Learn from multicentre registry data and comparative analyses of bifurcation stenting strategies tailored to STEMI care.
TAVI and the left ventricular myocardium
23 May 2025 – From EuroPCR 2025
Understand the intricate relationship between TAVI and left ventricular myocardium through discussions on cardiac damage stages, functional remodeling, and pharmacological interventions post-TAVR. This session also reviews prophylactic ECMO support in high-risk patients, offering a comprehensive perspective on optimizing TAVI outcomes.
When stent failure meets calcified lesions
23 May 2025 – From EuroPCR 2025
Address the challenges of stent failure in the context of calcified coronary lesions. This session features complex PCI cases involving intrastent rotational atherectomy, management of underexpanded stents, in-stent restenosis, and innovative off-label use of shock wave lithotripsy to tackle tough calcifications.
How to manage iatrogenic dissection of the left main trunk
23 May 2025 – From EuroPCR 2025
Gain critical insights into managing iatrogenic dissection of the left main trunk. This session covers challenging cases including stent migration and bailout two-stent strategies for longitudinal stent deformation, enhancing preparedness for these rare but serious complications.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
